CBD Clinical Trials

5 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Also known as: AVCN319301a, Cannabidiol, Epidiolex

Pipeline

Phase 2: 3

Top Sponsors

University of Calgary1
University Health Network, Toronto1
Sunnybrook Health Sciences Centre1
Massachusetts General Hospital1
King's College London1

Indications

Osteoarthritis of Knee1
Osteoarthritis, Hip1
Alzheimer's Disease1
Back Pain1
Depressive Symptoms1

Other4 trials

Cannabidiol Medication Intervention Trial

Phase 2

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

N/A

Cannabis (THC vs. CBD) in Multiple Sclerosis

Phase 2

Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study

N/A

Boston, Massachusetts1 trial

Cannabidiol for Reduction of Brain Neuroinflammation

Massachusetts General Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.